368 related articles for article (PubMed ID: 9607727)
21. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
[TBL] [Abstract][Full Text] [Related]
22. Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome.
Jääskeläinen J; Mongan NP; Harland S; Hughes IA
Hum Mutat; 2006 Mar; 27(3):291. PubMed ID: 16470553
[TBL] [Abstract][Full Text] [Related]
23. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
Steroids; 2013 Dec; 78(12-13):1288-92. PubMed ID: 24055831
[TBL] [Abstract][Full Text] [Related]
24. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
[TBL] [Abstract][Full Text] [Related]
25. A novel point mutation in the hormone binding domain of the androgen receptor associated with partial and minimal androgen insensitivity syndrome.
Galli-Tsinopoulou A; Hiort O; Schuster T; Messer G; Kuhnle U
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):149-54. PubMed ID: 12713250
[TBL] [Abstract][Full Text] [Related]
26. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.
Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA
J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872
[TBL] [Abstract][Full Text] [Related]
28. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
[TBL] [Abstract][Full Text] [Related]
29. Bridging structural biology and genetics by computational methods: an investigation into how the R774C mutation in the AR gene can result in complete androgen insensitivity syndrome.
Wu JH; Gottlieb B; Batist G; Sulea T; Purisima EO; Beitel LK; Trifiro M
Hum Mutat; 2003 Dec; 22(6):465-75. PubMed ID: 14635106
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
[TBL] [Abstract][Full Text] [Related]
31. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
[TBL] [Abstract][Full Text] [Related]
32. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.
Helsen C; Rocca MS; Nguyen TT; Eerlings R; Lee XY; De Block S; Vinanzi C; Di Millo F; Giagulli V; Voet A; Ferlin A; Claessens F
Protein Sci; 2023 Apr; 32(4):e4599. PubMed ID: 36806291
[TBL] [Abstract][Full Text] [Related]
33. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
[TBL] [Abstract][Full Text] [Related]
34. Structure of the homodimeric androgen receptor ligand-binding domain.
Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiology of androgen insensitivity syndromes: molecular and structural approaches of natural and engineered androgen receptor mutations at amino acid 743.
Poujol N; Lumbroso S; Térouanne B; Lobaccaro JM; Bourguet W; Sultan C
J Clin Endocrinol Metab; 2002 Dec; 87(12):5793-800. PubMed ID: 12466388
[TBL] [Abstract][Full Text] [Related]
36. A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.
Choong CS; Quigley CA; French FS; Wilson EM
J Clin Invest; 1996 Sep; 98(6):1423-31. PubMed ID: 8823308
[TBL] [Abstract][Full Text] [Related]
37. Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.
Imasaki K; Okabe T; Murakami H; Tanaka Y; Haji M; Takayanagi R; Nawata H
Mol Cell Endocrinol; 1996 Jun; 120(1):15-24. PubMed ID: 8809734
[TBL] [Abstract][Full Text] [Related]
38. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
39. Molecular biology of androgen insensitivity.
Jääskeläinen J
Mol Cell Endocrinol; 2012 Apr; 352(1-2):4-12. PubMed ID: 21871529
[TBL] [Abstract][Full Text] [Related]
40. Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.
Georget V; Térouanne B; Lumbroso S; Nicolas JC; Sultan C
J Clin Endocrinol Metab; 1998 Oct; 83(10):3597-603. PubMed ID: 9768671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
